Lot certificates published
Plain, secure packaging
Back to Research Articles
Inflammation Research

KPV: An α-MSH-Derived Tripeptide in Inflammatory-Pathway Research

KPV is the C-terminal tripeptide of α-melanocyte-stimulating hormone. This overview surveys its inflammatory-signaling and epithelial-transport research, including mouse-colitis findings described as at least partially independent of MC1R signaling.

Purely Peptides Research TeamJuly 21, 20267 min read
KPValpha-MSHtripeptideNF-kBPepT1inflammation research
Research Use Only. All compounds discussed are sold exclusively for laboratory and in vitro research purposes. Nothing on this page constitutes medical advice or recommendation for human use.

KPV (Lys-Pro-Val) is the C-terminal tripeptide fragment of α-melanocyte-stimulating hormone (α-MSH). Kannengiesser et al. studied KPV in mouse colitis models, including mice with nonfunctional MC1R, and described its effects as at least partially independent of MC1R signaling. This does not establish independence from every melanocortin receptor.

NF-κB Pathway Modulation

The most characterized line of KPV research concerns intracellular modulation of the NF-κB signaling cascade. In cultured epithelial and immune cells, KPV has been reported to reduce activation of NF-κB and downstream pro-inflammatory cytokine transcription. Dalmasso et al. studied human intestinal epithelial and immune cell lines and identified PepT1-mediated KPV uptake. In those cell lines, KPV did not raise cAMP despite melanocortin-receptor expression, and the authors concluded that its anti-inflammatory effect there was PepT1-mediated rather than melanocortin receptor-mediated.

PepT1-Mediated Epithelial Uptake

A distinctive feature of KPV research is its transport. As a di/tripeptide, KPV can be taken up by intestinal epithelial cells via the PepT1 (SLC15A1) oligopeptide transporter. This transporter-mediated entry has made KPV a frequent model compound in studies of intestinal epithelial inflammation, where PepT1 expression is itself a variable of interest.

Research Applications

  • NF-κB and pro-inflammatory cytokine pathway assays
  • KPV signaling in mouse colitis with nonfunctional MC1R
  • PepT1/SLC15A1 oligopeptide-transport research
  • Preclinical intestinal-epithelial inflammation models

References

  1. Dalmasso G, Charrier-Hisamuddin L, et al. PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation. Gastroenterology 2008. PMID: 18061177.
  2. Kannengiesser K, Maaser C, et al. Melanocortin-derived tripeptide KPV has anti-inflammatory potential in murine models of inflammatory bowel disease. Inflamm Bowel Dis 2008. PMID: 18092346.

This article summarizes publicly available research for educational purposes and does not constitute medical advice, a therapeutic claim, or a recommendation for human use. Products referenced are sold for laboratory research use only.

What the studies reported

Each finding describes one cited study in its stated model. These observations are specific to that study and do not establish effects in other settings.

KPV

Cell and tissue studies

Animal studies

All findings and references in the Research Library

Research Compounds Discussed